Analgesia in Total Hip Arthroplasty by Quadratus Lumborum Block
NCT ID: NCT03666260
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
179 participants
INTERVENTIONAL
2018-10-08
2021-07-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The "gold standard" of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block.
The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Techniques of Locoregional Analgesia in Total Knee Prosthesis Surgery : Block to the Adductor Channel Versus Peri-articular Local Infiltrations
NCT03620136
Assessment of PENG Block Analgesia Versus Intra-articular Infiltration in Hip Prosthesis Surgery
NCT06675916
Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery
NCT04555291
Quadratus Lumborum Block Versus Fascia Iliaca Nerve Block for Patients Undergoing Total Hip Replacement
NCT03551860
Compare Epidural vs. Lumbar Plexus Analgesia After Hip Arthroplasty
NCT02493621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a double-blind, randomized study in prospective inclusion with a superiority test. Two groups of patients will be compared: a group of patients with a quadratus lumborum block and a group of patients with a femoral block.
Management (quadratus lumborum block or femoral block) will be randomized. The randomization will be stratified on the type of anesthesia (spinal anesthesia and general anesthesia). Randomization will be done on the day of surgery to determine the patient's treatment group. The surgical procedure will not be modified by the participation of the patent in the study.
Patients who would benefit from total hip replacement surgery in the Reims University Hospital and who agreed to participate in the study were included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quadratus Lumborum Block arm
Quadratus Lumborum Block
Quadratus Lumborum Block with echography
Femoral block arm
femoral block
femoral block with echography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quadratus Lumborum Block
Quadratus Lumborum Block with echography
femoral block
femoral block with echography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients agreeing to participate in the research and having signed informed consent
* between 18 yo and 95 yo
* Patients affiliated to a social security system
Exclusion Criteria
* Patients with neuropathy
* Patients with an ASA score of 4
* Patients undergoing revision surgery for total hip arthroplasty
* Patients receiving anterior hip total hip replacement surgery
* Patients with a contraindication to the realization of the quadratus lumborum block, femoral block or spinal anesthesia (clinical coagulopathy, infection at the point of puncture ...)
* Patients refusing the proposed techniques
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Reims
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Damien JOLLY
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PO18122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.